Comparative Study of Proportion of S-Phase Cells in Ascites and Pleural Effusions in Ovarian Carcinoma Using antibromodeoxyuridine Monoclonal antibody and Dna Flow-Cytometry

References

• Gratzner HG. Monoclonal antibody to 5-bromodeoxyuridine and 5 iododeoxyuridine; a new reagent for detection of DNA replication. Science 1982; 218: 474–5
   PubMed Web of Science ®Google Scholar
• Cho K. G, Hoshino T., Nagashima T., Murovik J. A, Wilson CB. Prediction of tumor doubling time in recurrent meningiomas. Cell kinetics studies with bromodeoxyuridine labelling. J Neurosurg 1986; 65: 7904
   Google Scholar
• Hoshino T., Nagashima T., Murovic J., Levin E. M, Levin VA. Cell kinetic studies of in situ brain tumors with bromodeoxyuridine. Cytometry 1985; 6: 627–32
   PubMedGoogle Scholar
• Nagashima T., Hoshino T., Cho K. G, Senegor M., Waldman F., Nomura K. Comparison of bromodeoxyuridine labelling indices obtained from tissue sections and flow cytometry of the brain tumors. J Neurosurg 1988; 68: 388–92
   PubMedGoogle Scholar
• Gunduz N. The use of FITC-conjugated monoclonal antibodies for determination of S-phase cells with fluorescence microscopy. Cytometry 1985; 6: 597–601
   PubMedGoogle Scholar
• Wilson G. D, McAlly N. J, Dunphy E., Kärcher H., Pfragner R. The labelling Index of human and mouse tumors assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry. Cytometry 1985; 6: 641–7
   PubMedGoogle Scholar
• Yonmura Y., Sugiyama K., Fujimura T., et al. Correlation of DNA ploidy and proliferation activity in human gastric carcinoma. Cancer 1988; 62: 1497–502
   PubMedGoogle Scholar
• Tada T., Kodama T., Wanatabe S., Sato Y., Shimosato Y. Immunohistochemical cellkinetic study of human lung cancer using monoclonal antibody to bromodeoxyuridine. Jpn J Clin Oncol 1986; 16: 129–35
   PubMed Web of Science ®Google Scholar
• Morstyn G., Hsu S. M, Kinsella T., Gratzner H., Russo A., Mitchell JB. Bromodeoxyuridine in tumors and chromosomes detected with monoclonal antibody. J CLin Invest 1983; 72: 1844–50
   PubMed Web of Science ®Google Scholar
• Nemato R., Uchida K., Hattori K., et al. S-phase fraction of human bladder tumor measured in situ with bromodeoxyuridine labelling. J Urol 1988; 139: 286–9
   PubMedGoogle Scholar
• Boccadoro M., Redoglio V., Gavarotti P., Pilari A. Multiple myeloma cell kinetics: rapid and reliable evaluation using 5-bromo-2-deoxyuridine (Brd-Urd) incorporation detected by anti Brd-Urd monoclonal antibody. Turnori 1986; 72: 135–7
   Google Scholar
• Raza A., Bhayana R., Ucar K., Kirshner J., Preisler HD. Differences between labeling index and DNA histograms in assessing S-phase cells from a homogenous group of CML patients. Cytometry 1985; 6: 445–51
   PubMedGoogle Scholar
• Gustafson H., Tribukait B., Esposti PL. DNA profile and tumor progression in patients with superficial bladder tumors. Urol Res 1982; 10: 13–8
   PubMedGoogle Scholar
• Tribukait B. Clinical DNA flow cytometry. Med Oncol Tumor Pharmacother 1984; 1: 211–8
   PubMedGoogle Scholar
• Nbukait B. Flowcytometry in assessing the clinical aggressiveness of genitourinary neoplasms. World J Urol 1987; 5: 108–22
   Google Scholar
• Strang P., Eklund G., Stendahl U., Frankendal B. S-phase as predictor of early recurrences in carcinoma of the uterine cervix. Anticancer Res 1987; 7: 807–10
   PubMedGoogle Scholar
• Kimby E., Mellsted H., Nilsson B., Tribukait B., Bjorkholm M., Holm G. S-phase lymphocytes in chronic lymphocytic leukemia (CLL) in relation to immunoglobulin isotypes on the leukemic clone and to the disease activity. Leukemia 1987; 1: 432–6
   PubMed Web of Science ®Google Scholar
• Kimby E., Mellsted H., Nilsson B., et al. Blood lymphocyte characteristics as predictors of prognosis in chronic lymphocytic leukemia of B-cell type. Hematol Oncol 1988; 6: 47–55
   PubMedGoogle Scholar
• Dolobeare F., Gratzner H. G, Pallavicini M. G, Gray JW. Flowcytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 1983; 80: 5573–7
   PubMed Web of Science ®Google Scholar
• Baisch H., Gohde W., Linden WA. Analysis of PCP data to determine the fraction of cell in various phases of cell cycle. Radiat Environ Biophys 1976; 12: 31–9
   Google Scholar
• Morstyn G., Pyke K., Gardner J., Ashcroft R., de Fazio A., Bathal P. Immunohistochemical identification of proliferating cells in organ culture using bromodeoxyuridine and a monoclonal antibody. J Histochem Cytochem 1986; 34: 697–701
   PubMedGoogle Scholar
• Kikuyama S., Kuboto T., Watanabe M., et al. Cell kinetics in human xenografts using anti-bromodeoxyuridine and a monoclonal antibody. Jpn J Surg 1987; 17: 28–32
   PubMedGoogle Scholar
• Sasaki K., Murakami T., Ogino T., Takashi M., Kawaski S. Flow cytometric estimation of cell cycle parameters using monoclonal antibody to bromodeoxyuridine. Cytometry 1986; 7: 391–4
   PubMedGoogle Scholar
• Barlogie B., Spitzer G., Hartz J. S, et al. DNA histogram analysis of human hemopoietic cells. Blood 1976; 48: 245–58
   PubMed Web of Science ®Google Scholar
• Tribukait B., Hammarberg C., Rubio C. Ploidy and proliferation patterns in colorectal adenocarcinomas related to Dukes classification. A flow cytometric DNA study. Acta Pathol Microbiol Immunol Scand 1983; 91(Sect A)89–95
   Google Scholar